title: Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
authors.affiliation: Division of Hematology and Oncology Department of Medicine College of Medicine University of Florida Gainesville, Florida.
authors.forename: Martina
authors.initials: M
authors.lastname: Murphy
authors.forename: Julia
authors.initials: J
authors.lastname: Close
authors.forename: Richard
authors.initials: R
authors.lastname: Lottenberg
authors.forename: Anita
authors.initials: A
authors.lastname: Rajasekhar
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate